Literature DB >> 1609795

The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7.

D K Getman1, J H Eubanks, S Camp, G A Evans, P Taylor.   

Abstract

Acetylcholinesterase (AChE) is a secreted enzyme essential for regulating cholinergic neurotransmission at neuronal and neuromuscular synapses. In view of the altered expression of AChE in some central neurological and neuromuscular disorders with a probable genetic basis, we have identified the chromosomal location of the gene encoding AChE. Chromosomal in situ suppression hybridization analysis revealed a single gene to be at 7q22, a result which was confirmed by PCR analysis of genomic DNA from a human/hamster somatic cell hybrid containing a single human chromosome 7. The AChE gene thus maps to the same region in which frequent nonrandom chromosome 7 deletions occur in leukemias of myeloid cell precursors known to express the enzyme during normal differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1609795      PMCID: PMC1682883     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines.

Authors:  M Jücker; M Schaadt; V Diehl; S Poppema; D Jones; H Tesch
Journal:  Hematol Oncol       Date:  1990 Jul-Aug       Impact factor: 5.271

2.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  Assignment of the YT blood group locus to chromosome 7q.

Authors:  T Zelinski; L White; G Coghlan; S Philipps
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

4.  Refinement of the localization of human butyrylcholinesterase to chromosome 3q26.1-q26.2 using a PCR-derived probe.

Authors:  G Gaughan; H Park; J Priddle; I Craig; S Craig
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

Review 5.  The cholinesterases.

Authors:  P Taylor
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

6.  Mapping the human genome: current status.

Authors:  J C Stephens; M L Cavanaugh; M I Gradie; M L Mador; K K Kidd
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

7.  Refinement of human chromosome 7 map around the pro alpha 2(I)collagen gene by long-range restriction mapping.

Authors:  J Kere; R Tolvanen; H Donis-Keller; A de la Chapelle
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

8.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

9.  Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression.

Authors:  Y Li; S Camp; T L Rachinsky; D Getman; P Taylor
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  Molecular localization of the t(11;22)(q24;q12) translocation of Ewing sarcoma by chromosomal in situ suppression hybridization.

Authors:  L Selleri; G G Hermanson; J H Eubanks; K A Lewis; G A Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  13 in total

1.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 2.  Natural inhibitors of cholinesterases: implications for adverse drug reactions.

Authors:  M D Krasowski; D S McGehee; J Moss
Journal:  Can J Anaesth       Date:  1997-05       Impact factor: 5.063

3.  Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism.

Authors:  C F Bartels; T Zelinski; O Lockridge
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

4.  Characterization of butyrylcholinesterase from porcine milk.

Authors:  Ashima Saxena; Tatyana Belinskaya; Lawrence M Schopfer; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2018-06-15       Impact factor: 4.013

5.  Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos.

Authors:  R Ben Aziz-Aloya; S Seidman; R Timberg; M Sternfeld; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  The cholinesterases: analysis by pharmacogenomics in man.

Authors:  A M Valle; Z Radić; B K Rana; J B Whitfield; D T O'Connor; N G Martin; P Taylor
Journal:  Chem Biol Interact       Date:  2008-05-04       Impact factor: 5.192

7.  Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits.

Authors:  S Camp; S Bon; Y Li; D K Getman; A G Engel; J Massoulié; P Taylor
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  From Split to Sibenik: the tortuous pathway in the cholinesterase field.

Authors:  Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-05-20       Impact factor: 5.192

9.  Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).

Authors:  C Donger; E Krejci; A P Serradell; B Eymard; S Bon; S Nicole; D Chateau; F Gary; M Fardeau; J Massoulié; P Guicheney
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

10.  Acetylcholinesterase involvement in apoptosis.

Authors:  Xue-Jun Zhang; David S Greenberg
Journal:  Front Mol Neurosci       Date:  2012-04-10       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.